🫀 The Hidden Mitral Valve Guardian: How Lymphatics Could Transform Marfan Care

🫀 Can fixing the lymphatic system slow mitral valve degeneration in Marfan syndrome? This elegant JCI study identifies defective lymphangiogenesis and reduced ZFP36-mediated anti-inflammatory signaling as previously unrecognized drivers of myxomatous mitral valve disease. In a mouse model, restoring lymphatic function with VEGF-C156S or activating ZFP36 with fingolimod reduced inflammation and valve thickening, opening an exciting avenue for disease-modifying therapies. A fascinating mechanistic advance with real translational promise. 🎙️ #Cardiology #MarfanSyndrome #ValveDisease #Lymphatics #MedicalResearch